The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
about
Role of Receptor Tyrosine Kinase Signaling in Renal FibrosisTipping the balance from angiogenesis to fibrosis in CKDMesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical EvidenceWT1-dependent sulfatase expression maintains the normal glomerular filtration barrierA potential role for caveolin-1 in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and SrcChronic VEGF blockade worsens glomerular injury in the remnant kidney modelThe detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.Matrix Gla protein deficiency causes arteriovenous malformations in miceVascular endothelial growth factor-receptor 1 inhibition aggravates diabetic nephropathy through eNOS signaling pathway in db/db miceTransgenic rabbits with increased VEGF expression develop hemangiomas in the liver: a new model for Kasabach-Merritt syndrome.Thrombotic microangiopathy after kidney transplantation.Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease.Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.VEGF ameliorates tubulointerstitial fibrosis in unilateral ureteral obstruction mice via inhibition of epithelial-mesenchymal transitionUnderstanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitorsVascular endothelial growth factor-A, matrix metalloproteinase-1, and macrophage migration inhibition factor changes in the porcine remnant kidney model: evaluation by magnetic resonance imaging.Role of renal microcirculation in experimental renovascular disease.Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.HIV-associated nephropathy: role of mammalian target of rapamycin pathway.Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia.The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) siBevacizumab increases risk for severe proteinuria in cancer patients.Anti-VEGF Cancer Therapy in Nephrology PracticeInduction of podocyte VEGF164 overexpression at different stages of development causes congenital nephrosis or steroid-resistant nephrotic syndromeRenal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockadePOEMS syndrome, calciphylaxis and focal segmental glomerulosclerosis - VEGF as a possible link.What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?Isolation and epithelial co-culture of mouse renal peritubular endothelial cellsGIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.Immunoglobulin A nephropathy with massive paramesangial deposits caused by anti-vascular endothelial growth factor therapy for metastatic rectal cancer: a case report and review of the literature.Maternal vitamin D and fetal growth in early-onset severe preeclampsia.Risks of proteinuria associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a systematic review and meta-analysisRelevance of VEGF and nephrin expression in glomerular diseases.Aristolochic acid I and ochratoxin A differentially regulate VEGF expression in porcine kidney epithelial cells--the involvement of SP-1 and HIFs transcription factorsSilencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats.Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injuryThe vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathyExpression of VEGF in neonatal urinary obstruction: does expression of VEGF predict hydronephrosis?
P2860
Q26743407-631994E1-14F1-468E-8085-3F91086CF244Q26796634-CCC0DB23-4DAC-44BC-A48A-3C7A7297C2CCQ28079089-085360E5-0D9C-4A07-8D0B-93A737B8AEADQ28506573-F35606B6-694A-4F0B-8E2D-55D9B1519ADCQ28567391-EF218BD6-5716-43D3-99D7-C13C27DD4BCCQ28728129-42DC0A2C-BD63-40BD-B32E-2A1531CD01E2Q30497355-C3AB7F44-D74D-48F6-BE3F-664767C358E2Q30503158-40D5351E-85B8-40CC-9A39-E5B9F1FF7503Q31159383-199D0410-DF1A-4EEE-A404-F12FF5346BA5Q33368758-CD47A3AB-1BF9-4CA9-91A9-D03D730F5621Q33372586-052A68B3-01C1-4477-8FB9-00ABA93004E6Q33399420-7CAA27F4-2AC4-4737-8D1B-590760AB24D8Q33409827-F7B5CF98-8870-4805-8CFF-FD225C3DB64AQ33566806-BC2458B6-0629-4611-A5FB-A7D41B49E9A3Q33698419-3612277B-B558-40AC-A7DF-66D41ADB9106Q33984156-B01065B6-3A42-46DE-8563-1F87184DCA48Q33988621-E0F82DD3-5649-41F0-A953-C622C5D0F4BAQ33995115-677B37F9-1F6A-4CDA-B907-88EE54EDA7A8Q34033416-4C5D847A-18E4-439D-B041-DD679E987F4FQ34040304-B5E7C154-A65E-4270-A5C8-78C62AAFD429Q34122191-70F84FAD-A48D-426B-9FB3-FEBB3BDE1C6BQ34122321-B9C656A1-0060-4F5E-8450-0B9B2F0A123DQ34124173-B73D387B-E254-4FCE-836C-1C10A1B7F8E3Q34152125-B91A8B54-693D-45CF-B354-543E752721DBQ34254364-8A7A54A3-200C-4180-9E30-F1F92664BF2BQ34426346-8148F674-64CA-4583-BC5B-6111122A4354Q34484613-E9A51B96-2F57-4B4C-A263-4757F5514033Q34584614-E38D0D7F-E1A6-4072-ABD9-0BC21C8CB5B9Q34659563-9F82A7B3-E302-44F6-932C-ECA054D46BEBQ35027224-203FAF32-4F0E-4285-8C33-AD2A3F9D9404Q35037471-774CC476-E050-40CB-9D81-45E389169C7AQ35106064-E3139768-419C-4302-9374-DDAB5F3B1830Q35118673-200EAA68-455A-4743-AE40-2AF10B1A2FEFQ35131059-D0A43BDA-CD2B-497E-81EA-B19457C19EFEQ35158699-6D05B73A-2EC1-4581-8017-FEA311CB2DEBQ35216335-BA3C50B0-A963-41D6-B2BE-AF5DD32D0B14Q35304596-F86721E0-0DCC-47C9-9659-C140DA43B957Q35354723-0C258D65-0338-4A18-A5EB-C602521A44CBQ35433416-83D01F76-AAFC-411C-9F78-9BE27F59DF62Q35622269-5590A36C-CC32-4008-ACB5-A5ECD77C6B8F
P2860
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
@ast
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
@en
type
label
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
@ast
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
@en
prefLabel
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
@ast
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
@en
P1433
P1476
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
@en
P2093
An S De Vriese
Bieke F Schrijvers
P304
P356
10.1111/J.1523-1755.2004.00621.X
P407
P577
2004-06-01T00:00:00Z
P5875
P6179
1007727647